ENDRA has closed a private placement to fund its foray into digital assets, immediately deploying capital into a HYPE token position that forms the cornerstone of its active treasury management.
Summary
- ENDRA Life Sciences launched a digital-asset treasury, acquiring $3M in HYPE tokens.
- The move followed a $4.9m private placement led by institutional and crypto investors.
- HYPE token traded near $39.30 at the time of writing, up nearly 10% amid rising institutional interest.
According to a press release dated October 23, the Ann Arbor-based medical technology firm finalized a PIPE financing round raising $4.9 million, with institutional and crypto investors leading the charge.
Simultaneously, the company revealed it had allocated roughly $3 million of that capital to acquire 78,863 Hyperliquid (HYPE) tokens. ENDRA Life Sciences said the purchase represents the inaugural deployment of its newly formulated digital asset treasury, or DAT strategy.
The company’s CEO, Alexander Tokman, stated the move aligns the treasury with the “highest conviction” DeFi holdings of Arca Investment Management, which considers HYPE a core asset.
“This marks a foundational step in our long-term digital asset treasury strategy,” Tokman said. “By aligning with Arca’s most strategic positions in DeFi, we are not just preserving capital – we are actively putting it to work in some of the most innovative and yield-generating digital asset ecosystems in the world.”
ENDRA’s strategy expands beyond initial HYPE allocation
According to the company’s strategy outline, the HYPE position will serve as a foundational asset for a suite of active yield-enhancement techniques. These include sophisticated options overlays, direct staking within the Hyperliquid protocol, and participation in other DeFi mechanisms.
ENDRA said its ultimate goal is to increase its “tokens-per-share,” a novel metric that reframes shareholder value in terms of direct crypto asset ownership. This strategy aims to generate an income stream from its holdings, which can be reinvested to compound growth.
The company’s entry into the Hyperliquid ecosystem coincides with a significant surge in institutional interest surrounding the HYPE token. At the time of writing, HYPE is trading at $39.30, notching a nearly 10 percent gain according to crypto.news data. This upward momentum appears to be fueled by major structural developments within its own ecosystem.
The price surge was notably buoyed by news that Hyperliquid Strategies, a new digital asset treasury firm formed from a merger involving Sonnet BioTherapeutics, has filed with the SEC to raise $1 billion. A core stated purpose of this fundraise is to acquire HYPE tokens for its own treasury.
